Skip to main content
. Author manuscript; available in PMC: 2016 Jan 11.
Published in final edited form as: Ann Neurol. 2009 Apr;65(4):386–393. doi: 10.1002/ana.21675

Table 3B.

Changes in Electrophysiologic and JND Variables Between Baseline and Six Months, by Leg and Treatment Group

Treatment Group VEGF Placebo P value
Changes in Electrophysiologic Variables (Median, Interquartile Range)
Tibial Amplitude
    Untreated Leg 0.0 (−0.3, 0.1) −0.1 (−1.3, 0.0) 0.33
    Treated Leg 0.0 (−0.2, 0.1) −0.4 (−2.3, 0.0) 0.27
Peroneal Amplitude
    Untreated Leg 0.0 (−0.2, 0.1) 0.0 (−0.3, 0.6) 0.88
    Treated Leg 0.0 (−0.3, 0.0) 0.0 (−0.1, 0.9) 0.12
Amplitude Sum
    Untreated Leg 0.0 (−0.3, 0.1) 0.0 (−3.0, 0.4) 0.80
    Treated Leg −0.1 (−0.4, 0.0) 0.0 (−1.0, 0.1) 0.64
Sural Amplitude
    Untreated Leg 0.0 (0.0, 0.0) 0.0 (−0.5, 0.0) 0.44
    Treated Leg 0.0 (0.0, 0.0) 0.0 (−0.8, 0.0) 0.36
Changes in JND Measurements (Mean, Standard Error)
Cold
    Untreated Leg −0.15 (1.11) −3.14 (3.98) 0.31
    Treated Leg −0.68 (1.21) 2.01 (4.65) 0.30
Vibration
    Untreated Leg 0.84 (0.81) −1.66 (1.31) 0.15
    Treated Leg 0.07 (0.88) −0.43 (0.51) 0.69